Granulibacter bethesdensis, a Pathogen from Patients with Chronic Granulomatous Disease, Produces a Penta-Acylated Hypostimulatory Glycero-D-talo-oct-2-ulosonic Acid–Lipid A Glycolipid (Ko-Lipid A)
Authors:
- Artur MuszyńskiAMArtur Muszyński
- Kol A. ZaremberKZKol A. Zarember
- Christian HeissCHChristian Heiss
- Joseph ShiloachJSJoseph Shiloach
- Lars J. BergLBLars J. Berg
- John AudleyJAJohn Audley
- Arina KozyrAKArina Kozyr
- David E. GreenbergDGDavid E. Greenberg
- Steven M. HollandSHSteven M. Holland
- Harry L. MalechHMHarry L. Malech
- Parastoo AzadiPAParastoo Azadi
- Russell W. CarlsonRCRussell W. Carlson
Open Access
- 24 March 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (7) , 3303
Abstract
Granulibacter bethesdensis can infect patients with chronic granulomatous disease, an immunodeficiency caused by reduced phagocyte NADPH oxidase function. Intact G. bethesdensis (Gb) is hypostimulatory compared to Escherichia coli, i.e., cytokine production in human blood requires 10–100 times more G. bethesdensis CFU/mL than E. coli. To better understand the pathogenicity of G. bethesdensis, we isolated its lipopolysaccharide (GbLPS) and characterized its lipid A. Unlike with typical Enterobacteriaceae, the release of presumptive Gb lipid A from its LPS required a strong acid. NMR and mass spectrometry demonstrated that the carbohydrate portion of the isolated glycolipid consists of α-Manp-(1→4)-β-GlcpN3N-(1→6)-α-GlcpN-(1⇿1)-α-GlcpA tetra-saccharide substituted with five acyl chains: the amide-linked N-3′ 14:0(3-OH), N-2′ 16:0(3-O16:0), and N-2 18:0(3-OH) and the ester-linked O-3 14:0(3-OH) and 16:0. The identification of glycero-d-talo-oct-2-ulosonic acid (Ko) as the first constituent of the core region of the LPS that is covalently attached to GlcpN3N of the lipid backbone may account for the acid resistance of GbLPS. In addition, the presence of Ko and only five acyl chains may explain the >10-fold lower proinflammatory potency of GbKo–lipidA compared to E. coli lipid A, as measured by cytokine induction in human blood. These unusual structural properties of the G.bethesdensis Ko–lipid A glycolipid likely contribute to immune evasion during pathogenesis and resistance to antimicrobial peptides.Keywords
Funding Information
- National Institutes of Health (Intramural Programs of the National Institute for Allergy and In-fectious Diseases and National Institute of Diabetes and Digestive and Kidney Diseases, R24GM137782-01)
- U.S. Department of Energy (Office of Science, Basic Energy Sciences (BES); DE-SC0015662)
This publication has 47 references indexed in Scilit:
- Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate ImmunityFrontiers in Immunology, 2013
- Innate Immunity against Granulibacter bethesdensis, an Emerging Gram-Negative Bacterial PathogenInfection and Immunity, 2012
- Structures of the lipopolysaccharides from Rhizobium leguminosarum RBL5523 and its UDP-glucose dehydrogenase mutant (exo5)Glycobiology, 2010
- Altered Linkage of Hydroxyacyl Chains in Lipid A of Campylobacter jejuni Reduces TLR4 Activation and Antimicrobial ResistanceJournal of Biological Chemistry, 2010
- Purification and Characterization of the Lipid A 1-Phosphatase LpxE of Rhizobium leguminosarumJournal of Biological Chemistry, 2009
- Genome Sequence Analysis of the Emerging Human Pathogenic Acetic Acid Bacterium Granulibacter bethesdensisJournal of Bacteriology, 2007
- Lipid A Modification Systems in Gram-Negative BacteriaAnnual Review of Biochemistry, 2007
- Attenuated virulence of aFrancisellamutant lacking the lipid A 4′-phosphataseProceedings of the National Academy of Sciences, 2007
- First Report of Bacteremia by Asaia bogorensis , in a Patient with a History of Intravenous-Drug AbuseJournal of Clinical Microbiology, 2006
- A Novel Bacterium Associated with Lymphadenitis in a Patient with Chronic Granulomatous DiseasePLOS Pathogens, 2006